116 related articles for article (PubMed ID: 18309279)
1. Selection and target-site mapping of peptides inhibiting HCV NS5B polymerase using phage display.
Kim MS; Park C; Lee JH; Myung H
J Microbiol Biotechnol; 2008 Feb; 18(2):328-33. PubMed ID: 18309279
[TBL] [Abstract][Full Text] [Related]
2. Selection of peptides binding to HCV e2 and inhibiting viral infectivity.
Hong HW; Lee SW; Myung H
J Microbiol Biotechnol; 2010 Dec; 20(12):1769-71. PubMed ID: 21193836
[TBL] [Abstract][Full Text] [Related]
3. A homogeneous, solid-phase assay for hepatitis C virus RNA-dependent RNA polymerase.
Wang YK; Rigat KL; Roberts SB; Gao M
Anal Biochem; 2006 Dec; 359(1):106-11. PubMed ID: 17054898
[TBL] [Abstract][Full Text] [Related]
4. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of interaction between NS3 and NS5B protein of classical swine fever virus by deletion of terminal sequences of NS5B.
Wang Y; Zhu Z; Wang P; Yu J; Wan L; Chen J; Xiao M
Virus Res; 2011 Mar; 156(1-2):98-106. PubMed ID: 21237222
[TBL] [Abstract][Full Text] [Related]
6. Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase.
Kukolj G; McGibbon GA; McKercher G; Marquis M; Lefèbvre S; Thauvette L; Gauthier J; Goulet S; Poupart MA; Beaulieu PL
J Biol Chem; 2005 Nov; 280(47):39260-7. PubMed ID: 16188890
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro.
Lu L; Dekhtyar T; Masse S; Pithawalla R; Krishnan P; He W; Ng T; Koev G; Stewart K; Larson D; Bosse T; Wagner R; Pilot-Matias T; Mo H; Molla A
Antiviral Res; 2007 Oct; 76(1):93-7. PubMed ID: 17561278
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus (HCV) NS2 protein up-regulates HCV IRES-dependent translation and down-regulates NS5B RdRp activity.
She Y; Liao Q; Chen X; Ye L; Wu Z
Arch Virol; 2008; 153(11):1991-7. PubMed ID: 18853100
[TBL] [Abstract][Full Text] [Related]
9. Sequential determination of ligands binding to discrete components in heterogeneous mixtures by iterative panning and blocking (IPAB).
Messmer BT; Benham CJ; Thaler DS
J Mol Biol; 2000 Feb; 296(3):821-32. PubMed ID: 10677284
[TBL] [Abstract][Full Text] [Related]
10. [Selection and characterization of peptides that specifically binding to hepatitis C virus serine protease].
Du G; Hou L; Chen W; Zhang Y; Wang H
Wei Sheng Wu Xue Bao; 2002 Jun; 42(3):298-304. PubMed ID: 12557369
[TBL] [Abstract][Full Text] [Related]
11. Using capillary electrophoresis to study methylation effect on RNA-peptide interaction.
Mucha P; Szyk A; Rekowski P; Agris PF
Acta Biochim Pol; 2003; 50(3):857-64. PubMed ID: 14515166
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.
Matsubara T; Sumi M; Kubota H; Taki T; Okahata Y; Sato T
J Med Chem; 2009 Jul; 52(14):4247-56. PubMed ID: 19558186
[TBL] [Abstract][Full Text] [Related]
13. A new natural α-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV.
Yan R; Zhao Z; He Y; Wu L; Cai D; Hong W; Wu Y; Cao Z; Zheng C; Li W
Peptides; 2011 Jan; 32(1):11-9. PubMed ID: 20950663
[TBL] [Abstract][Full Text] [Related]
14. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
Xu J; Liu S; Xu Y; Tien P; Gao G
Virus Res; 2009 Apr; 141(1):55-62. PubMed ID: 19185598
[TBL] [Abstract][Full Text] [Related]
15. Identification of peptides that bind hepatitis C virus envelope protein E2 and inhibit viral cellular entry from a phage-display peptide library.
Lü X; Yao M; Zhang JM; Yang J; Lei YF; Huang XJ; Jia ZS; Ma L; Lan HY; Xu ZK; Yin W
Int J Mol Med; 2014 May; 33(5):1312-8. PubMed ID: 24573486
[TBL] [Abstract][Full Text] [Related]
16. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine.
Smith DB; Kalayanov G; Sund C; Winqvist A; Pinho P; Maltseva T; Morisson V; Leveque V; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M
J Med Chem; 2009 Jan; 52(1):219-23. PubMed ID: 19055482
[TBL] [Abstract][Full Text] [Related]
17. Interaction with a ubiquitin-like protein enhances the ubiquitination and degradation of hepatitis C virus RNA-dependent RNA polymerase.
Gao L; Tu H; Shi ST; Lee KJ; Asanaka M; Hwang SB; Lai MM
J Virol; 2003 Apr; 77(7):4149-59. PubMed ID: 12634373
[TBL] [Abstract][Full Text] [Related]
18. Selection of a phage-displayed peptide recognized by monoclonal antibody directed blocking the site of hepatitis C virus E2 for human CD81.
Cao J; Liao XL; Wu SM; Zhao P; Zhao LJ; Wu WB; Qi ZT
J Microbiol Methods; 2007 Mar; 68(3):601-4. PubMed ID: 17178166
[TBL] [Abstract][Full Text] [Related]
19. [Screening of proteins interacting with hepatitis C virus NS3 from T7-phage display library].
Huang Y; Cai XF; He MR; Zhang J; Huang AL
Zhonghua Gan Zang Bing Za Zhi; 2006 Aug; 14(8):561-4. PubMed ID: 16938163
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide channel of RNA-dependent RNA polymerase used for intermolecular uridylylation of protein primer.
Tellez AB; Crowder S; Spagnolo JF; Thompson AA; Peersen OB; Brutlag DL; Kirkegaard K
J Mol Biol; 2006 Mar; 357(2):665-75. PubMed ID: 16427083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
